AU2002349688A1 - Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives - Google Patents

Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives

Info

Publication number
AU2002349688A1
AU2002349688A1 AU2002349688A AU2002349688A AU2002349688A1 AU 2002349688 A1 AU2002349688 A1 AU 2002349688A1 AU 2002349688 A AU2002349688 A AU 2002349688A AU 2002349688 A AU2002349688 A AU 2002349688A AU 2002349688 A1 AU2002349688 A1 AU 2002349688A1
Authority
AU
Australia
Prior art keywords
egonol
derivatives
compositions containing
egonol derivatives
whitening agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002349688A
Inventor
Kenji Sakamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sakamoto Bio Co Ltd
Original Assignee
Sakamoto Bio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sakamoto Bio Co Ltd filed Critical Sakamoto Bio Co Ltd
Publication of AU2002349688A1 publication Critical patent/AU2002349688A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002349688A 2001-12-05 2002-12-03 Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives Abandoned AU2002349688A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001370991 2001-12-05
JP2001-370991 2001-12-05
PCT/JP2002/012648 WO2003047565A1 (en) 2001-12-05 2002-12-03 Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives

Publications (1)

Publication Number Publication Date
AU2002349688A1 true AU2002349688A1 (en) 2003-06-17

Family

ID=19180117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002349688A Abandoned AU2002349688A1 (en) 2001-12-05 2002-12-03 Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives

Country Status (5)

Country Link
JP (1) JP4632115B2 (en)
KR (1) KR20040074994A (en)
CN (1) CN1297268C (en)
AU (1) AU2002349688A1 (en)
WO (1) WO2003047565A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4568527B2 (en) * 2004-04-22 2010-10-27 ポーラ化成工業株式会社 Benzofuran derivative and external preparation for skin containing the same
KR100756669B1 (en) 2006-02-02 2007-09-10 이화여자대학교 산학협력단 Cosmetic composition comprising an extract of Persicae fructus having whitening activities

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2890212B2 (en) * 1991-01-29 1999-05-10 有限会社野々川商事 Cosmetics
JPH08217672A (en) * 1995-02-08 1996-08-27 Terumo Corp Antihelicobacter pylori agent containing xanthone derivative
JPH08231396A (en) * 1995-02-28 1996-09-10 Terumo Corp Anti-helicobacter pylori medicine
JPH0987155A (en) * 1995-09-27 1997-03-31 Shiseido Co Ltd Ultraviolet light absorber and skin preparation for external use obtained by blending the same
CN1281700A (en) * 1999-07-23 2001-01-31 李洋 Sulfur bacterium preparation for regulating gastointestinal function and production method thereof

Also Published As

Publication number Publication date
JP4632115B2 (en) 2011-02-16
CN1615132A (en) 2005-05-11
JPWO2003047565A1 (en) 2005-04-14
WO2003047565A1 (en) 2003-06-12
CN1297268C (en) 2007-01-31
KR20040074994A (en) 2004-08-26

Similar Documents

Publication Publication Date Title
HUP0400327A3 (en) Azole derivatives having metalloproteinase inhibitor effect pharmaceutical compositions containing them and their use
AU9025701A (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containingthe same
HUP0500173A3 (en) Alpha-sulphonamido-acetamide derivatives as beta-amyloid inhibitors and pharmaceutical compositions containing them
AU7392101A (en) 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
AU2002338858A8 (en) Stable compositions containing ethanolamine derivatives and glucosides
IL209444A0 (en) O-desmethyl-venlafaxine succinate salts and pharmaceutical compositions containing them
HUP0301269A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
IL156759A0 (en) Kits and pharmaceutical compositions containing epothilone derivatives
HUP0302412A3 (en) Betha-carboline derivatives useful as inhibitors of phosphodiesterase and pharmaceutical compositions containing the same
AU2001249361A1 (en) Stable alkaline hair bleaching compositions and method for use thereof
AU2001231045A1 (en) Personal cleansing compositions
AU2002230397A1 (en) Packaged scalp cosmetic compositions
HK1053107A1 (en) Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU2002345353A1 (en) Methods and compositions that affect melanogenesis (pfi-016cip/pct)
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
AU2001276027A1 (en) Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
AU2001267522A1 (en) Cosmetic compositions containing substituted amide derivatives
AU4834101A (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
EP1352637A4 (en) Hair growth inhibitors and compositions containing the same
HUP0402600A3 (en) D-proline derivatives and pharmaceutical compositions containing them
AU2002354353A1 (en) Melanogenesis inhibitors and whitening agents comprising ergosterol derivatives and compositions containing ergosterol derivatives
AU2002364911A1 (en) Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase